Valeant Pharmaceuticals International Inc
(NYSE : VRX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
ICPTIntercept Pharmaceuticals, Inc.
0.65%67.8122.0%$211.95m
ZGNXZogenix, Inc.
-1.56%37.9516.8%$134.08m
SHPGShire PLC Sponsored ADR
-2.51%151.380.4%$117.92m
VRXValeant Pharmaceuticals International, Inc.
-1.39%12.7414.2%$103.49m
PRGOPerrigo Co. Plc
0.57%87.546.5%$92.06m
AERIAerie Pharmaceuticals, Inc.
0.70%64.508.6%$67.41m
CTLTCatalent Inc
-1.14%41.502.7%$58.13m
MNKMallinckrodt Plc
-1.12%31.9217.7%$56.13m
PTLAPortola Pharmaceuticals, Inc.
-1.08%50.327.9%$52.98m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.12%111.387.6%$51.12m
JAZZJazz Pharmaceuticals Plc
-0.51%139.792.2%$49.96m
UTHRUnited Therapeutics Corporation
2.30%122.5414.4%$48.25m
SUPNSupernus Pharmaceuticals, Inc.
-0.24%41.106.4%$39.05m
ENDPEndo International Plc
-0.66%7.578.9%$38.58m
MDCOMedicines Company
-0.29%34.7822.1%$37.19m

Company Profile

Valeant Pharmaceuticals International, Inc. engages in the development, manufacture, and market of a broad range of pharmaceutical products in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. It operates through the following segments: The Bausch + Lomb/International, The Branded Rx, and The U.S. Diversified products. The Bausch + Lomb/International segment is consist of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Branded Rx segment is comprised of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women. The U.S. Diversified Products segment is the sales in the U.S. of pharmaceutical products, over-the-counter products, and medical device products in the areas of neurology and certain other therapeutics classes, including aesthetics and generic products in the U.S. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.